GlassScriptPhysician profile
George William Heffner
NPI 1396717815
$1,994.60
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,337 · 2020: $645 · 2021: $12.30.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $345.99 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $307.03 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $223.54 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $189.23 | 2019-2020 | |
| Amgen INC. | $176.27 | 2019-2020 | |
| Lilly USA, LLC | $173.98 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $143.43 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $59.14 | 2019-2020 | |
| Astellas Pharma US INC | $57.53 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $57.12 | 2019 | |
| Allergan, INC. | $56.92 | 2019-2020 | |
| Glaxosmithkline, LLC. | $41.17 | 2019-2020 | |
| Pfizer INC. | $34.71 | 2019-2020 | |
| Amarin Pharma, INC. | $27.67 | 2019 | |
| Boston Scientific Corporation | $20.59 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $15.81 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.61 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.36 | 2020 | |
| Merck Sharp & Dohme LLC | $13.33 | 2020 | |
| Horizon Therapeutics Plc | $12.13 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.04 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Heffner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.